BRUKER CORPORATION (NASDAQ: BRKR)

BRUKER CORPORATION

NASDAQ: BRKR (Bruker Corporation)

Last update: 22 Mar, 2:54PM

44.45

-0.02 (-0.04%)

Add to watchlist

Previous Close	44.47
Open	44.00
Volume	2,089,739
Avg. Volume (3M)	1,709,163
Market Cap	6,743,286,784

Price / Earnings (TTM)	58.49
Price / Earnings (Forward)	16.05
Price / Sales	1.79
Price / Book	3.44

52 Weeks Range	43.51 (-2%) — 94.64 (112%)
Earnings Date	30 Apr 2025 - 5 May 2025
TTM Dividend Yield	0.45%

Market Trend

		Short Term	Medium Term
Industry	Medical Devices (US)	Mixed	Mixed
	Medical Devices (Global)	Mixed	Mixed
Stock	Bruker Corporation	Bearish	Bearish

AIStockmoo Score

1.8

Analyst Consensus	1.0
Insider Activity	NA
Price Volatility	3.5
Technical Moving Averages	5.0
Technical Oscillators	-2.5
Average	1.75

Similar Stocks

Stock	Market Cap	DY	P/E (TTM)	P/B
BRKR	7 B	0.45%	58.49	3.44
MASI	9 B	-	-	9.55
LIVN	2 B	-	34.80	1.66
NVCR	2 B	-	-	5.47
ATEC	1 B	-	-	50.98
INMD	1 B	-	8.19	1.88

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.
Sector	Healthcare
Industry	Medical Devices
Investment Style	Small Core
% Held by Insiders	31.91%
% Held by Institutions	82.67%

Ownership

Name	Date	Shares Held
Pallas Capital Advisors Llc	31 Dec 2024	9,482,301

52 Weeks Range	43.51 (-2%) — 94.64 (112%)
Price Target Range	57.00 (28%) — 60.00 (34%)
High	60.00 (Barclays, 34.98%)	Buy
Median	58.50 (31.61%)
Low	57.00 (Stifel, 28.23%)	Hold
Average	58.50 (31.61%)
Total	1 Buy, 1 Hold
Avg. Price @ Call	50.04

Firm	Date	Target Price	Call	Price @ Call
Barclays	14 Feb 2025	60.00 (34.98%)	Buy	50.04
Barclays	10 Feb 2025	65.00 (46.23%)	Buy	51.13
Stifel	14 Feb 2025	57.00 (28.23%)	Hold	50.04

No data within this time range.

Date	Type	Details
02 Apr 2025	Announcement	Bruker Announces Introduction of Revolutionary d-DNP Polarizer for MRI Research and for Dynamic Nuclear Polarization Liquids NMR
27 Feb 2025	Announcement	Bruker Launches X4 POSEIDON™ Advanced X-Ray Microscope for Three-Dimensional Microscopy in Industrial and Scientific Applications
24 Feb 2025	Announcement	Bruker Advances Single-Cell Proteomics and Immunopeptidomics Performance; Unveils New Proteomics Software and Applications for Enhanced Biological Insights at US HUPO
21 Feb 2025	Announcement	Bruker Spatial Biology to Announce Groundbreaking Advances at AGBT 2025
21 Feb 2025	Announcement	Bruker Appoints Laura Francis to its Board of Directors
21 Feb 2025	Announcement	Bruker Announces Quarterly Dividend
20 Feb 2025	Announcement	Bruker Corporation to Present at Upcoming Investor Conferences
13 Feb 2025	Announcement	Bruker Reports Fourth Quarter and Full Year 2024 Financial Results
07 Feb 2025	Announcement	Bruker Announces Date and Time of Fourth Quarter 2024 Earnings Release and Webcast
08 Jan 2025	Announcement	Bruker Launches Infrared Imaging Microscope for Pharma and Life Science Research
07 Jan 2025	Announcement	Bruker Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Show more

TTM Dividend Yield	0.45%
5Y Average Dividend Yield	0.28%
Payout Ratio	26.32%
Expected Next Dividend Payment	Sep 2025

Ex Date	Announcement Date	Payment Date	Details
17 Mar 2025	18 Feb 2025	28 Mar 2025	0.05 Cash
02 Dec 2024	14 Nov 2024	16 Dec 2024	0.05 Cash
30 Aug 2024	08 Aug 2024	16 Sep 2024	0.05 Cash
03 Jun 2024	14 May 2024	17 Jun 2024	0.05 Cash
29 Feb 2024	15 Feb 2024	15 Mar 2024	0.05 Cash
30 Nov 2023	17 Nov 2023	15 Dec 2023	0.05 Cash
31 Aug 2023	09 Aug 2023	15 Sep 2023	0.05 Cash
31 May 2023	11 May 2023	16 Jun 2023	0.05 Cash
28 Feb 2023	16 Feb 2023	17 Mar 2023	0.05 Cash
30 Nov 2022	10 Nov 2022	16 Dec 2022	0.05 Cash
31 Aug 2022	11 Aug 2022	16 Sep 2022	0.05 Cash
31 May 2022	13 May 2022	17 Jun 2022	0.05 Cash
28 Feb 2022	17 Feb 2022	18 Mar 2022	0.05 Cash
30 Nov 2021	11 Nov 2021	17 Dec 2021	0.04 Cash
31 Aug 2021	05 Aug 2021	17 Sep 2021	0.04 Cash
28 May 2021	12 May 2021	18 Jun 2021	0.04 Cash
04 Mar 2021	17 Feb 2021	19 Mar 2021	0.04 Cash
30 Nov 2020	11 Nov 2020	18 Dec 2020	0.04 Cash
31 Aug 2020	06 Aug 2020	18 Sep 2020	0.04 Cash
29 May 2020	12 May 2020	19 Jun 2020	0.04 Cash
06 Mar 2020	-	20 Mar 2020	0.04 Cash
29 Nov 2019	-	20 Dec 2019	0.04 Cash
30 Aug 2019	-	20 Sep 2019	0.04 Cash
31 May 2019	-	21 Jun 2019	0.04 Cash
04 Mar 2019	-	22 Mar 2019	0.04 Cash
30 Nov 2018	-	21 Dec 2018	0.04 Cash
31 Aug 2018	-	21 Sep 2018	0.04 Cash
01 Jun 2018	-	22 Jun 2018	0.04 Cash
05 Mar 2018	-	23 Mar 2018	0.04 Cash
01 Dec 2017	-	22 Dec 2017	0.04 Cash
31 Aug 2017	-	22 Sep 2017	0.04 Cash
01 Jun 2017	-	23 Jun 2017	0.04 Cash
06 Mar 2017	21 Feb 2017	24 Mar 2017	0.04 Cash
01 Dec 2016	10 Nov 2016	23 Dec 2016	0.04 Cash
01 Sep 2016	-	23 Sep 2016	0.04 Cash
02 Jun 2016	13 May 2016	24 Jun 2016	0.04 Cash
02 Mar 2016	-	24 Mar 2016	0.04 Cash
Show more

Annual Dividend Yield

Year	Annual Dividend ($)	Frequency/Year	Yield %
2025	0.050	1	0.11
2024	0.200	4	0.34
2023	0.200	4	0.27
2022	0.200	4	0.29
2021	0.160	4	0.19
2020	0.160	4	0.30
2019	0.160	4	0.31
2018	0.160	4	0.54
2017	0.160	4	0.47
2016	0.160	4	0.76
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

Realized Profit	-
Unrealized Profit	-
Dividend Received 2025	-
Total Profit	-
Avg. Return	-
Quantity (Buy)	-
Avg. Price (Buy)	-
Quantity (Sold)	-
Avg. Price (Sold)	-

No stocks matching your criteria

Profit Margin	3.36%
Operating Margin (TTM)	16.72%
Diluted EPS (TTM)	0.760
Quarterly Revenue Growth (YOY)	14.60%
Quarterly Earnings Growth (YOY)	-93.30%

Total Debt/Equity (MRQ)	123.69%
Current Ratio (MRQ)	1.60
Operating Cash Flow (TTM)	251.30 M
Levered Free Cash Flow (TTM)	284.20 M

Return on Assets (TTM)	5.10%
Return on Equity (TTM)	7.05%

Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)